Gotham Makker, Director at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 274,000 shares at $28.43 ($7.8M) on 2024-03-21, disclosed to the SEC on 2024-03-25.
Open-market sale of $7.8M RCKT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RCKT | SELL | 2021-06-21 | $3.3M | — | Filing → |